The New York Eye & Ear Infirmary   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: New York City NY United States (1820)

Organization Overview

First Clinical Trial
2000
NCT00570726
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

New York Eye & Ear Infirmary | The New York Eye & Ear Infirmary

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 3)

Alopecia Areata (Phase 3)

Diabetic Retinopathy (Phase 1)

Gastroesophageal Reflux (Phase 1)

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 1)

Macular Degeneration (Phase 4)

Macular Edema (Phase 4)

Retinal Diseases (Phase 1)

Retinal Vein Occlusion (Phase 4)

Scotoma (Phase 3)

Sleep Apnea, Obstructive (Phase 1)

Syndrome (Phase 1)

Thyroid Diseases (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 20